文献速递胰腺与胆道疾病

蛋白酶敏感性胰脂肪酶变异与早发性慢性胰腺炎相关

Protease-Sensitive Pancreatic Lipase Variants Are Associated With Early Onset Chronic Pancreatitis.
PubMed 文献 · Am J Gastroenterol · 2019-01-01

研究在德国、法国、日本等队列中对慢性胰腺炎患者和对照进行PNLIP外显子测序,发现蛋白酶敏感性PNLIP错义变异在德国发现队列患者中富集(1.9% vs 0.3%,P=0.02,OR=5.7),在法国早发性慢性胰腺炎患者中亦富集(0.8% vs 0.1%,P=0.04,OR=7.6),合并欧洲数据OR=11.3(95%CI 3.0-49.9,P<0.0001),非欧洲人群未检出。

要点

  • 蛋白酶敏感性PNLIP变异在德国慢性胰腺炎患者中富集:8/429(1.9%)vs 2/600(0.3%),P=0.02,OR=5.7。
  • 法国早发性慢性胰腺炎患者中蛋白酶敏感性变异富集:5/632(0.8%)vs 1/957(0.1%),P=0.04,OR=7.6。
  • 合并欧洲数据OR=11.3(95%CI 3.0-49.9,P<0.0001),非欧洲人群未检出蛋白酶敏感性变异。

核心结论

  • 蛋白酶敏感性PNLIP变异是慢性胰腺炎发生的新型遗传风险因素。

研究设计与样本

  • 病例对照遗传关联研究,对德国429例非酒精性慢性胰腺炎患者和600例对照、法国632例患者和957例对照、日本223例患者和1,070例对照的PNLIP全部13个外显子进行DNA测序。
  • 另对来自德国、美国、印度的545例慢性胰腺炎患者和1,849例对照的选定外显子进行分析。
  • 评估重组PNLIP变异的细胞分泌、脂肪酶活性和蛋白水解稳定性。

主要发现

  • 德国发现队列中,8/429(1.9%)患者和2/600(0.3%)对照携带PNLIP错义变异(P=0.02,OR=5.7,95%CI 1.1-38.9)。
  • 患者中检测到的变异易被胰蛋白酶和糜蛋白酶蛋白水解降解。
  • 法国复制队列中,蛋白酶敏感性变异在早发性慢性胰腺炎患者中富集:5/632(0.8%)vs 对照1/957(0.1%)(P=0.04,OR=7.6,95%CI 0.9-172.9)。
  • 非欧洲人群中未检测到蛋白酶敏感性变异。
  • 合并欧洲数据中,蛋白酶敏感性变异见于13/1,163例病例(1.1%)和3/3,000例对照(0.1%)(OR=11.3,95%CI 3.0-49.9,P<0.0001)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 法国复制队列中蛋白酶敏感性变异富集的OR=7.6,95%CI=0.9-172.9,未达统计学显著。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Premature activation of the digestive protease trypsin within the pancreatic parenchyma is a critical factor in the pathogenesis of pancreatitis. Alterations in genes that affect intrapancreatic trypsin activity are associated with chronic pancreatitis (CP). Recently, carboxyl ester lipase emerged as a trypsin-independent risk gene. Here, we evaluated pancreatic lipase (PNLIP) as a potential novel susceptibility gene for CP. METHODS: We analyzed all 13 PNLIP exons in 429 nonalcoholic patients with CP and 600 control subjects from Germany, in 632 patients and 957 controls from France, and in 223 patients and 1,070 controls from Japan by DNA sequencing. Additionally, we analyzed selected exons in further 545 patients with CP and 1,849 controls originating from Germany, United States, and India. We assessed the cellular secretion, lipase activity, and proteolytic stability of recombinant PNLIP variants. RESULTS: In the German discovery cohort, 8/429 (1.9%) patients and 2/600 (0.3%) controls carried a PNLIP missense variant (P = 0.02, odds ratio [OR] = 5.7, 95% confidence interval [CI] = 1.1-38.9). Variants detected in patients were prone to proteolytic degradation by trypsin and chymotrypsin. In the French replication cohort, protease-sensitive variants were also enriched in patients with early-onset CP (5/632 [0.8%]) vs controls (1/957 [0.1%]) (P = 0.04, OR = 7.6, 95% CI = 0.9-172.9). In contrast, we detected no protease-sensitive variants in the non-European populations. In the combined European data, protease-sensitive variants were found in 13/1,163 cases (1.1%) and in 3/3,000 controls (0.1%) (OR = 11.3, 95% CI = 3.0-49.9, P < 0.0001). CONCLUSIONS: Our data indicate that protease-sensitive PNLIP variants are novel genetic risk factors for the development of CP.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Lasher D, Szabó A, Masamune A, et al. Protease-Sensitive Pancreatic Lipase Variants Are Associated With Early Onset Chronic Pancreatitis. Am J Gastroenterol. 2019. PMID: 30789418. doi:10.14309/ajg.0000000000000051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。